Literature DB >> 5052977

Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels.

W C Duckworth, S S Solomon, A E Kitabchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5052977     DOI： 10.1210/jcem-35-4-585

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  20 in total

1.  Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone.

Authors:  E Bonora; P Moghetti; M Querena; M Zenere; V Cacciatori; F Tosi; D Travia; G Zoppini; M Muggeo
Journal:  J Endocrinol Invest       Date:  1992-01       Impact factor: 4.256

2.  Chronic exposure to glibenclamide impairs insulin secretion in isolated rat pancreatic islets.

Authors:  D Gullo; A M Rabuazzo; M Vetri; C Gatta; C Vinci; M Buscema; R Vigneri; F Purrello
Journal:  J Endocrinol Invest       Date:  1991-04       Impact factor: 4.256

3.  Pharmacological Agents Utilized in Patients With Type-2 Diabetes: Beyond Lowering A1c.

Authors:  Joanna W Chung; Melody L Hartzler; Ashley Smith; Jessica Hatton; Kristi Kelley
Journal:  P T       Date:  2018-04

4.  A novel mechanism of glipizide sulfonylurea action: decreased metabolic clearance rate of insulin.

Authors:  N Barzilai; P H Groop; L Groop; R A DeFronzo
Journal:  Acta Diabetol       Date:  1995-12       Impact factor: 4.280

Review 5.  The biochemistry of diabetes.

Authors:  R Taylor; L Agius
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

6.  Extrapancreatic action of the sulphonylurea gliquidone: post-receptor effect on insulin-stimulated glycogen synthesis in rat hepatocytes in primary culture.

Authors:  F Rinninger; D Kirsch; H U Häring; W Kemmler
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

Review 7.  Oral hypoglycaemic agents. An update.

Authors:  A C Asmal; A Marble
Journal:  Drugs       Date:  1984-07       Impact factor: 9.546

8.  Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effect.

Authors:  W P Bieger; R Dlugosch; A Rettenmeier; H D Holler; H Bert; W Schwarz; W Fiehn; J Merkt; H Weicker
Journal:  Klin Wochenschr       Date:  1984-07-02

9.  Studies on the biological activity of an insulin-stimulating peptide from a tryptic digest of bovine serum albumin.

Authors:  A Ueno; N Arakaki; T Oribe; Y Takeda
Journal:  Mol Cell Biochem       Date:  1986-05       Impact factor: 3.396

10.  Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects.

Authors:  P M Clark; J C Levy; L Cox; M Burnett; R C Turner; C N Hales
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.